10 June, 2017
The firm earned "Sector Perform" rating on Thursday, November 5 by RBC Capital Markets. The stock increased 3.21% or $1.02 on June 9, reaching $32.77. About 9.50M shares traded. Mylan N.V. (NASDAQ:MYL) has declined 7.73% since June 8, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.
The counter witnessed a trading volume of 0.79 million shares versus an average volume of 0.87 million shares during last trading session. The company has a market cap of $3.36 billion, a price-to-earnings ratio of 20.70 and a beta of 1.11. Van Hulzen Asset Mngmt Limited Company holds 2.02% of its portfolio in Mylan N.V. (NASDAQ:MYL) for 120,878 shares.
Westlake Chemical Corporation is a global manufacturer and marketer of basic chemicals, vinyls, polymers and building products. The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.30. Rhumbline Advisers holds 0.01% of its portfolio in Westlake Chemical Corporation (NYSE:WLK) for 100,855 shares. It has outperformed by 5.06% the S&P500.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 16th. Bnp Paribas Arbitrage Sa stated it has 0% in Westlake Chemical Corporation (NYSE:WLK).
Since March 1, 2017, it had 0 insider buys, and 3 selling transactions for $1.72 million activity. $542,786 worth of Westlake Chemical Corporation (NYSE:WLK) was sold by Buesinger Robert F. Pennsylvania-based Stevens L P has invested 0.01% in Chemical Financial Corporation (NASDAQ:CHFC).
Among 41 analysts covering Amazon.com (NASDAQ:AMZN), 38 have Buy rating, 0 Sell and 3 Hold. Chemical Financial's payout ratio is now 50.47%. Finally, Hilliard Lyons upgraded shares of Chemical Financial to a "buy" rating and lifted their price target for the stock from $54.00 to $55.00 in a report on Friday, April 28th. $397,557 worth of Chemical Financial Corporation (NASDAQ:CHFC) was sold by Lievense Richard M. on Monday, January 30. JP Morgan maintained Westlake Chemical Corporation (NYSE:WLK) rating on Tuesday, August 16. RBC Capital Markets upgraded the shares of WLK in report on Tuesday, August 23 to "Outperform" rating. The firm has "Outperform" rating given on Tuesday, May 23 by Cowen & Co.
Investors sentiment decreased to 1.26 in 2016 Q4. Its down 0.03, from 1.29 in 2016Q3. It is positive, as 46 investors sold WFT shares while 88 reduced holdings. (CHFC) opened at 47.21 on Friday. 121,972 were accumulated by Kennedy Capital Management. Tortoise Advisors Limited Liability holds 7,764 shares or 0% of its portfolio.
Public Employees Retirement Association of Colorado maintained its stake in shares of Chemical Financial Co.
Azimuth Capital Mgmt Lc holds 0.02% or 4,500 shares in its portfolio. Alliancebernstein LP has 24,276 shares. Following the sale, the chief financial officer now owns 58,243 shares of the company's stock, valued at approximately $3,746,189.76. Nomura Asset Company Ltd accumulated 320 shares. 76,753 were reported by Cornerstone Capital Management Com. Guggenheim Cap Llc owns 46,575 shares or 0.01% of their U.S. portfolio. Rosenblum Silverman Sutton S F Ca owns 14,587 shares for 5.17% of their portfolio.
AXA boosted its stake in Chemical Financial Co. Westlake Chemical Corporation (NYSE:WLK) has risen 45.05% since June 7, 2016 and is uptrending. Hudson Bay Capital Mngmt LP reported 52,802 shares or 0.06% of all its holdings. Gsa Cap Prtnrs Limited Liability Partnership reported 5,779 shares.
Shapiro Capital Management Llc, which manages about $4.00 billion and $3.90B US Long portfolio, decreased its stake in Dolby Laboratories Inc. Its up 1.83% from 2.27 million shares previously. It also increased its holding in Sanofi (Put) (NYSE:SNY) by 136,342 shares in the quarter, for a total of 599,700 shares, and has risen its stake in Communications Sales & Leasing Inc. Regardless, closing prices are a useful tool that investors use to quantify changes in stock prices over time. Occidental Petroleum Corp (NYSE:OXY) was reduced too. (NYSE:PFE) were released by: Seekingalpha.com and their article: "Pfizer: What's Going On?" published on June 05, 2017 as well as Seekingalpha.com's news article titled: "Pfizer shrugs off potential ire from politicians; hikes prices 20%" with publication date: June 02, 2017. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. Therefore 35% are positive. Pfizer had 44 analyst reports since July 29, 2015 according to SRatingsIntel. Smithfield Tru Commerce reported 750 shares. Credit Suisse maintained it with "Hold" rating and $124 target in Monday, March 27 report. As per Friday, January 29, the company rating was maintained by UBS. Berenberg initiated it with "Buy" rating and $140 target in Thursday, October 13 report. (NYSE:PFE) has "Neutral" rating given on Monday, April 18 by Goldman Sachs. Argus Research has "Buy" rating and $108.0 target. Argus Research upgraded Accenture Plc (NYSE:ACN) rating on Tuesday, September 8.
The company maintained ROI for the last twelve months at -6.50%.
HCR Wealth Advisors purchased a new stake in Westlake Chemical Co.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
